B-type natriuretic peptide (BNP): can it improve our management of patients with congestive heart failure?

B-type natriuretic peptide (BNP): can it improve our management of patients with congestive heart failure?

Bibliographic Details
Main Author:	Swiss Medical Weekly
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2002-11-01
Series:	Swiss Medical Weekly
Subjects:	natriuretic peptides Congestive Heart failure heart failure BNP
Online Access:	https://www.smw.ch/index.php/smw/article/view/227

Similar Items

B-type natriuretic peptide for diagnosis and treatment of congestive heart failure
by: GM Kuster, et al.
Published: (2002-11-01)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
by: Mihai Marinescu, et al.
Published: (2023-04-01)

The integration of BNP and NT-proBNP into clinical medicine
by: Swiss Medical Weekly
Published: (2007-01-01)

Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure—A Comparative Review
by: Tanja Gangnus, et al.
Published: (2019-01-01)

Relationship Between Prohormone Brain Natriuretic Peptide (NT-proBNP) Level and Severity of Pulmonary Dysfunction in Patients With Chronic Congestive Heart Failure
by: Nazemiyeh Masoud, et al.
Published: (2015-03-01)

Serum brain natriuretic peptide (BNP) and N-terminal brain natriuretic peptide (NT-proBNP) in heart valve disease
by: J.A. Moolman, et al.
Published: (2017-04-01)

B-Type Natriuretic Peptide (BNP) Revisited—Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
by: Toshio Nishikimi, et al.
Published: (2022-07-01)

Natriuretic peptides: Diagnostic and therapeutic use
by: Kaushik Pandit, et al.
Published: (2011-01-01)

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
by: F. Fernandes, et al.
Published: (2007-02-01)

Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes
by: Emil Wolsk, et al.
Published: (2022-04-01)

Recombinant human brain natriuretic peptide ameliorates venous return function in congestive heart failure
by: Jing‐chao Luo, et al.
Published: (2022-08-01)

NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
by: Isaac R. Whitman, et al.
Published: (2019-04-01)

Clinical, Laboratory and Lung Ultrasound Assessment of Congestion in Patients with Acute Heart Failure
by: Alberto Palazzuoli, et al.
Published: (2022-03-01)

Comparability of Results Between a Point-of-Care and an Automated Instrument for Measurement of B-Type Natriuretic Peptide
by: Shah, Kevin, et al.
Published: (2010-02-01)

The Role of B-Type Natriuretic Peptide in the Diagnosis of Congestive Heart Failure in Patients Presenting to an Emergency Department with Dyspnea
by: Humberto Villacorta, et al.
Published: (2002-12-01)

Development of a Rapid Diagnostic Kit for Congestive Heart Failure Using Recombinant NT-proBNP Antigen
by: Young-Ki Lee, et al.
Published: (2021-07-01)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
by: Claire Sweeney, et al.
Published: (2021-12-01)

ANALYSIS OF CHANGE IN NT-proBNP AFTER ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY IN PATIENT WITH HEART FAILURE
by: Intan Kusuma Dewi, et al.
Published: (2017-08-01)

Anaemia and Congestion in Heart Failure: Correlations and Prognostic Role
by: Pietro Scicchitano, et al.
Published: (2023-03-01)

How to Use Natriuretic Peptides in Patients with Heart Failure with Non-Reduced Ejection Fraction?
by: Ahmet Çelik, et al.
Published: (2023-05-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure
by: Roberto Valle, et al.
Published: (2016-02-01)

N‐terminal brain natriuretic peptide, cardiac troponin‐I, and point‐of‐care ultrasound in dogs with cardiac and noncardiac causes of nonhemorrhagic ascites
by: Alice G. N. Morey, et al.
Published: (2023-05-01)

Role of Brain Natriuretic Peptide assay in identifying children with pneumonia complicated by congestive cardiac failure
by: Wilson Sadoh, et al.
Published: (2018-12-01)

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE
by: Halla Hisan Hartoto, et al.
Published: (2017-08-01)

Brain natriuretic peptide, structural and functional cardiac remodeling in chronic heart failure with overweight and obesity
by: V. D. Syvolap, et al.
Published: (2014-06-01)

Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?
by: Rui Feng, et al.
Published: (2023-10-01)

Natriuretic peptides and their usefulness in clinical practise
by: Aleksandra Skałecka, et al.
Published: (2020-09-01)

Brain natriuretic peptide as a predictor of heart failure in patients with permanent pacemaker
by: Jelić Vera, et al.
Published: (2007-01-01)

Value of mid-regional pro-atrial natriuretic peptide and brain natriuretic peptide for detection of acute heart failure in patients with dyspnea: diagnostic accuracy study
by: Kambiz Masoumi, et al.
Published: (2023-08-01)

Acute on chronic heart failure—Which variations on B‐type natriuretic peptide levels?
by: Paulo Bettencourt PhD, et al.
Published: (2021-06-01)

Highest Obesity Category Associated With Largest Decrease in N‐Terminal Pro‐B‐Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction
by: Joban Vaishnav, et al.
Published: (2020-08-01)

ProBNP for stratifying patients with heart failure
by: Antonio Carlos Pereira-Barretto, et al.
Published: (2003-09-01)

Plasma B-type natriuretic peptide concentration for diagnosis of acute heart failure with renal insufficiency
by: Naila Atik Khan, et al.
Published: (2016-07-01)

Heart failure with normal ejection fraction (HFNEF): is it worth considering?
by: Swiss Medical Weekly
Published: (2010-02-01)

Accuracy of B-natriuretic peptide for the diagnosis of decompensated heart failure in muscular dystrophies patients with chronic respiratory failure
by: Paris Meng, et al.
Published: (2018-12-01)

Natriuretic Peptide‐Based Screening to Identify Stage B Heart Failure in People With Type 1 Diabetes
by: William B. Horton, et al.
Published: (2024-02-01)

Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide
by: Mauro Riccardi, et al.
Published: (2023-11-01)

Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial
by: Ambarish Pandey, et al.
Published: (2018-11-01)

Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery
by: Akihisa Kimura, et al.
Published: (2021-12-01)